Rachel Marusak Hermann

Rachel Marusak Hermann

WHO Member States Hammering Out Details On Non-Communicable Diseases

In a single voice, public health authorities spoke out about the need to take on the world’s heaviest disease burdens including cancer, diabetes, cardiovascular and chronic respiratory diseases. Now negotiations are narrowing in on the specifics of how to prevent and control these diseases, and achieving agreement on some commitments, including those related to medicine availability, could prove more challenging.

A Look At Who’s Who In Geneva IP Policymaking And Beyond

Doesn’t it always seem like as soon as you know who covers what at the permanent missions in Geneva, terms end, new assignments begin and you’re left exchanging business cards again? Well, we have it sorted with a substantial (but non-exhaustive) list of delegates responsible for IP issues this year in the world’s centre of diplomacy. Additionally, you’ll find the latest IP people news across national and regional governments, nonprofit organisations, and the private sector.

Keeping Pace With The IP Crowd’s Latest Moves

From government appointments and committee creations to key additions in the non-profit sector and industry advocacy’s revolving door, we’ve kept up with all of the latest hires, resignations, retirements and promotions over the past few months so you don’t miss a beat. Check out who you need to know.

World Health Assembly: Members Gavel New Mechanism To Fight Poor-Quality Medicines

World Health Organization member states have decided to establish a new mechanism for international collaboration to prevent and control “substandard, spurious, falsely-labelled, falsified and counterfeit medical products” (SSFFC). Excluding trade and intellectual property considerations, this mechanism is called to approach the problem strictly from a public health perspective.